BACKGROUND: Southwestern Uganda has high malaria heterogeneity despite moderate vector control and other interventions.
BACKGROUND: Artesunate-amodiaquine (AS-AQ) is one of the most widely used artemisinin-based combination therapies (ACTs) to treat uncomplicated Plasmodium falciparum malaria in Africa.
In the context of malaria elimination, novel strategies for detecting very low malaria parasite densities in asymptomatic individuals are needed.
Acute malnutrition is associated with increased morbidity and mortality risk.
In some parts of western Africa, Ebola treatment centers (ETCs) have reached capacity. Unless capacity is rapidly scaled up, the chance to avoid a generalized Ebola epidemic will soon diminish.
Mycobacterium tuberculosis strains of the Beijing lineage are globally distributed and are associated with the massive spread of multidrug-resistant (MDR) tuberculosis in Eurasia.
